CLINICAL_TRIALS
trial_result
· 2021-06-01
Clinical Trial Update: A Safety and Effectiveness Study of SABER®-Bupivacaine for Pain Following Shoulder Surgery [Phase 2]
Summary
Phase 2 clinical trial update for SABER®-Bupivacaine in postoperative shoulder pain, reporting safety and effectiveness results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Durect | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-06-01